Retraction
ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer
Paper Information
Record ID:
31426
Journal:
Publication Date:
February 08, 2021
Retraction Date:
July 19, 2021
(4.3 years years ago)
Subjects:
Institutions:
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
- Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China
- National Clinical Research Centre for Digestive Diseases, Beijing, China
- Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3389/fonc.2021.734761Additional Notes:
see also: https://pubpeer.com/publications/A7CE51FD141302AB653B90DB300BB4
Citations (2)
2
Total Citations1
Post-Retraction(50.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
479
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
miRNA-223-3p regulates ECT2 to promote proliferation, invasion, and metastasis of gastric cancer through the Wnt/β-catenin signaling pathway
Lin Li, Pengwei Liu, Chiyi He et al. (4 authors)
Journal of Cancer Research and Clinical Oncology
Published: Nov 2022
10 citations
10 citations
479 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025